However, traditional formulations are associated with a number of adverse effects, most notably dry mouth. A study comparing a new topical gel formulation ... once-daily oral oxybutynin ...

A frequent reason for discontinuation of therapy is dry mouth, which is reported by as many as 80% of patients receiving the immediate-release formulation of oxybutynin (widely considered the ...

Discover a study where patients reported symptom relief as early as one week after starting treatment, with continued ...